SCHEMBL5362002

SCHEMBL5362002

CC(C)(C)[SiH2]OC(C)(C)C1(c2ccccc2)CCN(CC(=O)c2ccc(Cl)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
DRD2 P14416 3/20 0.41
SSTR1 P30872 1/20 0.41
SSTR4 P31391 1/20 0.41
ALDH1A1 P00352 3/20 0.39
GRIN2B Q13224 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
MAPK1 P28482 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 1/20 0.38
ADRA1A P35348 1/20 0.38
POLB P06746 1/20 0.38
OPRM1 P35372 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366545 0.83 CCR3 (0.47) MEN1KMT2ADRD2ALDH1A1DRD4
SCHEMBL5369330 0.82 SLC6A9 (0.38) MEN1KMT2ADRD2DRD4DRD3
SCHEMBL5375844 0.80 GAA (0.40) MEN1KMT2AGRIN2BCYP3A4GAA
SCHEMBL5361865 0.78 HSD11B1 (0.42) MEN1KMT2ADRD2ALDH1A1DRD4
SCHEMBL5369345 0.78 SLC6A2 (0.36) MEN1KMT2ADRD2DRD4DRD3
SCHEMBL5361995 0.73 KMT2A (0.43) KDRMEN1KMT2ADRD2SSTR1
SCHEMBL4874296 0.72 ALDH1A1 (0.71) KDRMEN1KMT2AALDH1A1MAPK1
SCHEMBL5362770 0.72 MEN1 (0.47) MEN1KMT2ACYP2C19OPRM1SMN1; SMN2
SCHEMBL14417130 0.71 KDR (0.42) KDRMEN1KMT2ADRD2SSTR1
SCHEMBL11620077 0.70 DRD2 (0.46) KDRMEN1KMT2ADRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217823-B2 4,4-Disubstituted piperidines, and methods of use thereof SEPRACOR INC. (US) 2007-05-15 US disclosed
US-20040142974-A1 4,4-disubstituted piperidines, and methods of use thereof HOEMANN MICHAEL Z (US) 2004-07-22 US disclosed
US-6656953-B2 Ligands for receptors such as dopamine, serotonin, or norepinephrine transporters; broad uses claimed, such as pain reliever and antidepressant SEPRACOR INC. 2003-12-02 US disclosed
US-20020177607-A1 4,4-Disubstitued piperidines, and methods of use thereof SEPRACOR INC. 2002-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177607-A1 4,4-Disubstitued piperidines, and methods of use thereof HTR2C, HTR5A, OPRL1 KDR 2730/4885MEN1 2148/4885KMT2A 1835/4885
US-20040142974-A1 4,4-disubstituted piperidines, and methods of use thereof HTR5A, HTR2C, OPRL1 KDR 2090/4885MEN1 1787/4885KMT2A 1721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.